par Esme Fowler-Mason | Nov 27, 2025 | Healthcare Systems, NCD Solutions, Actualités
Noncommunicable diseases (NCDs) are on the rise across low- and middle-income countries (LMICs), adding pressure to already complex health supply chains. Ensuring consistent, affordable access to essential NCD medicines remains a critical, and often under-addressed,...
par Esme Fowler-Mason | Oct 23, 2025 | Access to Care, NCD Solutions, Actualités
Rituximab, a life-saving monoclonal antibody used in the treatment of blood cancers, is now available as a biosimilar through NCDconnect, ensuring quality, affordability, and access to targeted cancer therapies across low- and middle-income countries (LMICs). Pharmacy...
par Esme Fowler-Mason | Oct 7, 2025 | Behind the Scenes
For our Meet the Team series, we spoke with Suby Sanju, Strategic Sourcing Manager at IDA Foundation in Mumbai. Suby plays a key role in sourcing medicines for the NCDconnect platform, ensuring that quality, affordable treatments for noncommunicable diseases (NCDs)...
par Esme Fowler-Mason | Juil 15, 2025 | Access to Care, NCD Solutions, Actualités
The collaboration between IDA Foundation’s NCDconnect initiative and the Access to Oncology Medicines (ATOM) Coalition, led by the Union for International Cancer Control (UICC), is making significant strides toward improving access to cancer care in low- and...
par Esme Fowler-Mason | Juin 26, 2025 | Access to Care, NCD Partnerships, Actualités
In many low- and middle-income countries (LMICs), a childhood cancer diagnosis often comes with limited access to timely treatment, essential medicines, and consistent care. That’s why earlier this year, NCDconnect—through IDA Foundation—joined the Access Cancer...
